Galapagos is a biopharmaceutical company based in Belgium that discovers and develops medicines for inflammatory diseases and other serious conditions. It has worked on small-molecule treatments, including a medicine for rheumatoid arthritis and ulcerative colitis developed with a partner, and it is building a pipeline in cell therapy and oncology. Its customers are mainly healthcare providers and patients through partners and its own commercial operations in Europe.
Galapagos N.V. trades under the code 0JXZ on the London Stock Exchange in UK, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #1546 of 3788 on the London Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendFair
64/100
Mixed trend against its averages.
See the numbers →
Above 200-day average8.4%
From 52-week high-6.8%
MomentumFair
66/100
Typical recent returns for this exchange.
See the numbers →
3-month return13.3%
6-month return15.4%
12-month, skipping last month-2.9%
Stability (higher is calmer)Fair
63/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)28.8%
Worst drawdown, 1 year (smaller is calmer)-25.2%
LiquidityWeak
24/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.05M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 22.38 – 30.52Daily closes, split-adjusted
Signals
50-day average25.66
200-day average25.89
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.70
Technical summary
Daily
Strongly bullish
12 bullish · 1 neutral · 3 bearish
Weekly
Strongly bullish
10 bullish · 1 neutral · 1 bearish
Monthly
Bullish
5 bullish · 1 neutral · 2 bearish
Moving averages (daily)
SMA 10
27.18
Bullish
EMA 10
27.41
Bullish
SMA 20
26.70
Bullish
EMA 20
26.86
Bullish
SMA 50
25.66
Bullish
EMA 50
26.02
Bullish
SMA 100
25.35
Bullish
EMA 100
25.65
Bullish
SMA 200
25.89
Bullish
EMA 200
25.77
Bullish
Oscillators (daily)
RSI (14)
63.86
Neutral
MACD (12, 26)
0.66
Bullish
Momentum (12)
6.97
Bullish
Stochastic %K (14)
81.79
Bearish
Williams %R (14)
-18.21
Bearish
CCI (20)
187.0
Bearish
Pivot points (classic, last session)
S3
28.08
S2
28.08
S1
28.08
Pivot
28.08
R1
28.08
R2
28.08
R3
28.08
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
